Myeloid Therapeutics, Inc., a clinical stage oncology company, has appointed Matthew Maurer, M.D. as Chief Medical Officer. Dr. Maurer is an experienced physician-scientist with...
Immunitas Therapeutics, a clinical stage precision immunotherapy company committed to discovering and developing novel, differentiated therapeutics for patients with cancer, announced the appointment of...
Exact Sciences Corp., a leading provider of cancer screening and diagnostic tests, will present new data and study results across its Precision Oncology and...
Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
Inflammatix, Inc., a pioneering molecular diagnostics company, announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device Designation to the company's...
